Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles

Pharmaceutical Biology

Volumn 53, Issue 10, 2015, Pages 1525-1538

  Eskandani, Morteza ^a,b   Barar, Jaleh ^a,b   Dolatabadi, Jafar Ezzati Nazhad ^a,b   Hamishehkar, Hamed ^b   Nazemiyeh, Hossein ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticancer; Ferula ovina; Galbanic acid; Sesquiterpene coumarin; Sustained drug delivery

Indexed keywords

CASPASE 9; DNA; GALBANIC ACID; PROTEIN BCL XL; SOLID LIPID NANOPARTICLE; COUMARIN DERIVATIVE; CYTOTOXIN; LIPID; NANOPARTICLE;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BCL XL GENE; CANCER INHIBITION; CASP 9 GENE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG FORMULATION; DRUG IDENTIFICATION; DRUG RELEASE; DRUG STRUCTURE; GENE EXPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; ONCOGENE; UMBILICAL VEIN ENDOTHELIAL CELL; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; MEDICINAL CHEMISTRY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

FERULA;

CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; COUMARINS; CYTOTOXINS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPIDS; NANOPARTICLES;

EID: 84919921336     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.991836     Document Type: Article

References (49)

1. Abdelbary G, Fahmy RH. (2009). Diazepam-loaded solid lipid nanoparticles: Design and characterization. AAPS PharmSciTech 10:211-19.
2. Bedniak AE. (1962). On the problem of the isolation of galbanic acid from Ferula gumosa Boiss.roots. Aptechn Delo 12:28-34.
3. Cha MR, Choi YH, Choi CW, et al. (2011). Galbanic acid, a cytotoxic sesquiterpene from the gum resin of Ferula asafoetida, blocks protein farnesyltransferase. Planta Med 77:52-4.
4. Das S, Ng WK, Tan RB. (2012). Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47:139-51.
5. Eskandani M, Golchai J, Pirooznia N, et al. (2010). Oxidative stress level and tyrosinase activity in vitiligo patients. Indian J Dermatol 55:15-19.
6. Eskandani M, Hamishehkar H, Ezzati Nazhad Dolatabadi J. (2013). Cyto/genotoxicity study of polyoxyethylene (20) sorbitan monolaurate (Tween 20). DNA Cell Biol 32:498-503.
7. Eskandani M, Hamishehkar H, Ezzati Nazhad Dolatabadi J. (2014). Cytotoxicity and DNA damage properties of tert-butylhydroquinone (TBHQ) food additive. Food Chem 153:315-20.
8. Eskandani M, Nazemiyeh H. (2014). Self-reporter shikonin-Act-loaded solid lipid nanoparticle: Formulation, physicochemical characterization and geno/cytotoxicity evaluation. Eur J Pharm Sci 59:49-57.
9. Ezzati Nazhad Dolatabadi J, Hamishehkar H, Eskandani M, et al. (2014). Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles. Colloids Surf B 117:21-8.
10. Ghaffari S, Varshosaz J, Saadat A, et al. (2011). Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles. Int J Nanomed 6:35-43.
11. Ghasemi S, Davaran S, Sharifi S, et al. (2013). Comparison of cytotoxic activity of L778123 as a farnesyltranferase inhibitor and doxorubicin against A549 and HT-29 cell lines. Adv Pharm Bull 3:73-7.
12. Hamishehkar H, Khani S, Kashanian S, et al. (2014). Geno- and cytotoxicity of propyl gallate food additive. Drug Chem Toxicol 37:241-6.
13. Han J, Chen T-X, Branford-White CJ, et al. (2009). Electrospun shikonin-loaded PCL/PTMC composite fiber mats with potential biomedical applications. Int J Pharm 382:215-21.
14. Hanafi-Bojd MY, Iranshahi M, Mosaffa F, et al. (2011). Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines. Planta Med 77:1590-3.
15. Hu F-Q, Jiang S-P, Du Y-Z, et al. (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B 45:167-73.
16. Huang G, Zhang N, Bi X, et al. (2008). Solid lipid nanoparticles of temozolomide: Potential reduction of cardial and nephric toxicity. Int J Pharm 355:314-20.
17. Iranshahi M, Arfa P, Ramezani M, et al. (2007). Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes. Phytochemistry 68:554-61.
18. Iranshahi M, Masullo M, Asili A, et al. (2010). Sesquiterpene coumarins from Ferula gumosa. J Nat Prod 73:1958-62.
19. Kafil V, Omidi Y. (2011). Cytotoxic impacts of linear and branched polyethylenimine nanostructures in A431 cells. Bioimpacts 1:23-30.
20. Kheradmandnia S, Vasheghani-Farahani E, Nosrati M, et al. (2010). Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nanomedicine: NBM 6:753-9.
21. Kim KH, Lee HJ, Jeong SJ, et al. (2011). Galbanic acid isolated from Ferula assafoetida exerts in vivo antitumor activity in association with antiangiogenesis and antiproliferation. Pharm Res 28:597-609.
22. Kohno S, Murata T, Sugiura A, et al. (2011). Methyl galbanate, a novel inhibitor of nitric oxide production in mouse macrophage RAW264.7 cells. J Nat Med 65:353-9.
23. Li Y, Dong L, Jia A, et al. (2006). Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int J Biol Macromol 38:296-9.
24. Luo Y, Chen D, Ren L, et al. (2006). Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release 114:53-9.
25. Mansurov MM, Martirosov MS. (1988). Effect of the sodium salt of galbanic acid on thrombocyte aggregation. Farmakol Toksikol 51:47-8.
26. Matthaiou EI, Barar J, Sandaltzopoulos R, et al. (2014). Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer. Int J Nanomed 9:1855-70.
27. Mehnert W, Mäder K. (2001). Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 47:165-96.
28. Meng H, Li G, Huang J, et al. (2013). Sesquiterpene coumarin and sesquiterpene chromone derivatives from Ferula ferulaeoides (Steud.) Korov. Fitoterapia 86:70-7.
29. Müller RH, Mäder K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art. Eur J Pharm Biopharm 50:161-77.
30. Nath M, Vats M, Roy P. (2013). Tri- and diorganotin (IV) complexes of biologically important orotic acid: Synthesis, spectroscopic studies, in vitro anticancer, DNA fragmentation, enzyme assays and in vivo antiinflammatory activities. Eur J Med Chem 59:310-21.
31. Parveen R, Ahmad FJ, Iqbal Z, et al. (2013). Solid lipid nanoparticles of anticancer drug andrographolide: Formulation, in vitro and in vivo studies. Drug Dev Ind Pharm 40:1206-12.
32. Prombutara P, Kulwatthanasal Y, Supaka N, et al. (2012). Production of nisin-loaded solid lipid nanoparticles for sustained antimicrobial activity. Food Control 24:184-90.
33. Rostami E, Kashanian S, Azandaryani AH, et al. (2014). Drug targeting using solid lipid nanoparticles. Chem Phys Lipids 181:56-61.
34. Schwarz C, Mehnert W. (1999). Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsul 16:205-13.
35. Shahverdi AR, Fakhimi A, Zarrini G, et al. (2007). Galbanic acid from Ferula szowitsiana enhanced the antibacterial activity of penicillin G and cephalexin against Staphylococcus aureus. Biol Pharm Bull 30:1805-7.
36. Shi F, Zhao JH, Liu Y, et al. (2012). Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil. Int J Nanomed 7:2033-43.
37. Singh NP, Mccoy MT, Tice RR, et al. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-91.
38. Suresh G, Manjunath K, Venkateswarlu V, et al. (2007). Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS PharmSciTech 8:E162-70.
39. Syrov VN, Khushbaktova ZA, Nabiev AN. (1990). The effect of galbanic acid on the course of experimental hepatitis. Farmakol Toksikol 53:41-3.
40. Tiyaboonchai W, Tungpradit W, Plianbangchang P. (2007). Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 337:299-306.
41. Tsujimoto K, Ono T, Sato M, et al. (2005). Regulation of the expression of caspase-9 by the transcription factor activator protein-4 in glucocorticoid-induced apoptosis. J Biol Chem 280:27638-44.
42. Van Engeland M, Nieland LJ, Ramaekers FC, et al. (1998). Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1-9.
43. Vandghanooni S, Eskandani M. (2011). Comet assay: A method to evaluate genotoxicity of nano-drug delivery system. Bioimpacts 1:87-97.
44. Vandghanooni S, Eskandani M, Montazeri V, et al. (2011). SurvivindeltaEx3: A novel biomarker for diagnosis of papillary thyroid carcinoma. J Cancer Res Ther 7:325-30.
45. Vandghanooni S, Forouharmehr A, Eskandani M, et al. (2013). Cytotoxicity and DNA fragmentation properties of butylated hydroxyanisole. DNA Cell Biol 32:98-103.
46. Vu HL, Troubetzkoy S, Nguyen HH, et al. (2000). A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis. Nucleic Acids Res 28:E18 (1-9).
47. Wang W, Zhu R, Xie Q, et al. (2012). Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomed 7:3667-77.
48. Zhang Y, Kim KH, Zhang W, et al. (2012). Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells. Int J Cancer 130:200-12.
49. Zur Mühlen A, Schwarz C, Mehnert W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism. Eur J Pharm Biopharm 45:149-55.